[Case Report: Three Pediatric Pulmonary Cryptococcosis Patients with Prominent Manifestation of Mediastinal

Xiao-Yan Zhang1, Shun-Ying Zhao1, Chun-Ju Zhou2

  • 1Department Ⅱ of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.

Insights

Pulmonary cryptococcosis in immunocompetent children can manifest as prominent mediastinal lymphadenopathy. Early diagnosis and treatment with antifungals like fluconazole lead to successful outcomes.

Area of Science:

  • Pediatric Infectious Diseases
  • Pulmonology
  • Mycology

Background:

  • Pulmonary cryptococcosis is typically seen in immunocompromised individuals.
  • Mediastinal lymphadenopathy is an uncommon presentation in pediatric pulmonary fungal infections.

Observation:

  • Three immunocompetent children presented with persistent fever, mild cough, and significant mediastinal lymphadenopathy.
  • Elevated white blood cell counts, neutrophil counts, and C-reactive protein (CRP) were noted.
  • Serum cryptococcal antigen (sCRAG) was positive in two patients.

Findings:

  • Chest imaging revealed marked mediastinal lymph node enlargement in all patients.
  • Histological examination of lymph node biopsies showed Cryptococcus neoformans.
  • Two patients received a definitive diagnosis, and one received a clinical diagnosis of pulmonary cryptococcosis.

Implications:

  • Mediastinal lymphadenopathy should be considered in the differential diagnosis of pulmonary infections in immunocompetent children.
  • Antifungal therapy, including fluconazole alone or in combination with amphotericin B, is effective.
  • Prompt diagnosis and treatment result in favorable outcomes.

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
524
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
655
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
418
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
268
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
230